Comprehensive Nano - Post Market Clinical Follow-Up Study
NCT ID: NCT03423953
Last Updated: 2025-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
194 participants
OBSERVATIONAL
2013-10-30
2030-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
This is a Study to Evaluate Nanofractures Technique in the Treatment of Cartilage Lesions
NCT05660161
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
NCT01542580
Persona Ti-Nidium Post-Market Clinical Follow-up
NCT04817969
Comprehensive Segmental Revision System
NCT03270982
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
NCT05619588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This project is a prospective study including one-hundred and fifty (150) anatomic and hemi cases and 44 reverse shoulders collected from up to ten (10) sites. All potential study subjects will be required to participate in the Informed Consent process.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anatomic
Patients receiving the Anatomic or Hemi verison of the Comprehensive Nano.
Comprehensive Nano
Patients requiring the Comprehensive Nano shoulder system.
Reverse
Patients who have received the Reverse version of the Comprehensive Nano.
Comprehensive Nano
Patients requiring the Comprehensive Nano shoulder system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Comprehensive Nano
Patients requiring the Comprehensive Nano shoulder system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity.
* Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate
* Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate
Exclusion Criteria
* Sepsis
* osteomyelitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paola Vivoda
Role: STUDY_DIRECTOR
Zimmer Biomet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Privatklinik Leech
Graz, Styria, Austria
Kingston General Hospital
Kingston, Ontario, Canada
Chonnam National University Hospital
Gwangju, , South Korea
Samsung Medical Centre
Seoul, , South Korea
University of Liverpool
Liverpool, Merseyside, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORTHO.CR.GE2.13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.